Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Chiron/Ortho v. Roche

This article was originally published in The Gray Sheet

Executive Summary

Chiron and immunodiagnostics partner Ortho Diagnostics Systems file patent infringement claims in the Northern District Court of California and in the District Court of The Hague, The Netherlands against Hoffmann La Roche alleging that Roche's hepatitis C polymerase chain reaction assays infringe Chiron's newly-issued U.S. patents 5,712,088 and 5,714,596, and its longer-standing European patent EP318,216. Both suits ask the courts to enjoin Roche from further sales of its HCV PCR tests and to pay Chiron/Ortho "unspecified damages," Chiron says. Previous HCV-related patent infringement suits brought by Chiron/Ortho resulted in settlements favoring Chiron/Ortho's European patent position. In September 1996, Chiron/Ortho and International Murex settled their patent dispute by entering a worldwide licensing agreement ("The Gray Sheet" Sept. 2, 1996, I&W-7). In October 1995, Organon Teknika agreed to stop selling its HCV assays in Europe and paid Chiron/Ortho a compensatory lump-sum payment for past infringement...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009622

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel